Nisa Investment Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$175K Sell
4,493
-14,354
-76% -$464K ﹤0.01% 1299
2026
Q1
$613K Sell
18,847
-2,526
-12% -$81.2K ﹤0.01% 905
2025
Q4
$752K Buy
21,373
+7,700
+56% +$273K ﹤0.01% 898
2025
Q3
$359K Buy
13,673
+13,600
+18,630% +$406K ﹤0.01% 1109
2025
Q2
$1.94K Sell
73
-1,100
-94% -$29K ﹤0.01% 2614
2025
Q1
$28.3K Buy
1,173
+1,100
+1,507% +$34.8K ﹤0.01% 1758
2024
Q4
$2.94K Sell
73
-50,000
-100% -$2.85M ﹤0.01% 2391
2024
Q3
$3.17M Buy
50,073
+49,176
+5,482% +$2.89M 0.02% 533
2024
Q2
$47.5K Buy
897
+1
+0.1% +$66 ﹤0.01% 1685
2024
Q1
$73.5K Buy
896
+836
+1,393% +$37.2K ﹤0.01% 1558
2023
Q4
$1.12K Buy
60
+20
+50% +$262 ﹤0.01% 2246
2023
Q3
$443 Sell
40
-1,642
-98% -$23.5K ﹤0.01% 2550
2023
Q2
$27.3K Buy
+1,682
New +$35.2K ﹤0.01% 1969
2019
Q4
Sell
-7,900
Closed -$54K 2039
2019
Q3
$54K Hold
7,900
﹤0.01% 1529
2019
Q2
$66K Hold
7,900
﹤0.01% 1475
2019
Q1
$79K Hold
7,900
﹤0.01% 1471
2018
Q4
$60K Buy
+7,900
New +$94.5K ﹤0.01% 1436

Other funds holding VKTX

Nisa Investment Advisors's VKTX Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Viking Therapeutics (VKTX) stake by 76% in Q2 2026, selling an estimated $464K and leaving 4,493 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #1299.

Nisa Investment Advisors first reported a position in VKTX in Q4 2018 and has held it in 17 quarters since. The position peaked at $3.17M in Q3 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Nisa Investment Advisors held 4,493 shares of Viking Therapeutics worth $175K as of Q2 2026.
  • Nisa Investment Advisors sold 14,354 Viking Therapeutics shares in Q2 2026, an estimated $464K.
  • Viking Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1299 holding.
  • Nisa Investment Advisors first reported a position in Viking Therapeutics in Q4 2018 and has held it in 17 quarters since.
  • Nisa Investment Advisors's Viking Therapeutics position peaked at $3.17M in Q3 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.